FDA Adverse Event Injury Summary report: N

TAXUS ELEMENT PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 2193233 · Received August 5, 2011

Report

Report Number
2134265-2011-03447
Event Type
Injury
Date Received
August 5, 2011
Date of Event
June 23, 2011
Report Date
July 11, 2011
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
P100023
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
ES
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS COMBINATION PRODUCT. PATIENT IDENTIFIER: (B)(6). DEVICE EVALUATED BY MFR: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

(B)(4). IT WAS REPORTED THAT POST A STENTING TREATMENT PROCEDURE, MYOCARDIAL INFARCTION OCCURRED. THE PATIENT PRESENTED DUE TO STABLE ANGINA (CCS CLASS2). CARDIAC CATHETERIZATION REVEALED A 90% STENOSED AND 18MM LONG LESION LOCATED IN THE PROXIMAL LEFT CIRCUMFLEX CORONARY ARTERY WITH A REFERENCE VESSEL DIAMETER OF 2.75MM. THE LESION WAS TREATED WITH PREDILATION AND PLACEMENT OF A 2.75X20MM TAXUS ELEMENT STENT RESULTING IN 0% RESIDUAL STENOSIS. THE SAME DAY POST PROCEDURE, THE PATIENT WAS FOUND TO HAVE ELEVATED CARDIAC ENZYMES (PEAK TROPONIN= 1.4 MCG/L, ULN= 0.2 MCG/L, PEAK CKMB= 7.8 MCG/L, ULN= 3.1 MCG/L) AND WAS DIAGNOSED AS HAVING A MYOCARDIAL INFARCTION. NO ACTION WAS TAKEN TO TREAT THIS EVENT AND IT WAS CONSIDERED RESOLVED WITHOUT RESIDUAL EFFECTS. THE PATIENT WAS DISCHARGED 1 DAY LATER.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS ELEMENT PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - GALWAY H7493902520270 14310289

Patients

Seq Age Sex Outcome Treatment
1 64 YR Other